LP
PFE icon

Longaeva Partners’s Pfizer PFE Stock Holding History

Longaeva Partners’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13.5M Buy
+480,000
New +$12.8M 0.5% 57

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Longaeva Partners's PFE Position: Q1 2026 in Review

Longaeva Partners opened a new position in Pfizer (PFE) in Q1 2026: 560,615 shares worth $15.7M. The stake represents 0.58% of the portfolio and ranks #50 among its holdings.

2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Longaeva Partners held 560,615 shares of Pfizer worth $15.7M as of Q1 2026.
  • Pfizer was a new Longaeva Partners position in Q1 2026.
  • Pfizer made up 0.58% of Longaeva Partners's portfolio in Q1 2026, its #50 holding.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Longaeva Partners's 13F filing for Q1 2026, filed 15 May 2026.